• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT 5F VASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT 5F VASCULAR STENT Back to Search Results
Catalog Number 5F060403CS
Medical Device Problem Codes Break (1069); Detachment of Device or Device Component (2907); Device-Device Incompatibility (2919)
Health Effect - Clinical Code Thrombosis/Thrombus (4440)
Date of Event 10/23/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records is currently is being performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.H10: d4 (expiry date: 07/2025).H11: section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that during a stent placement procedure in the left superficial femoral artery via common femoral access, the guidewire allegedly felt resistance when advanced inside the delivery system and then the stent was delivered and removed successfully.It was further reported that there was an unknown object was found in the artery and when the delivery system was verified it was allegedly found that the tip of the delivery system was missing.Reportedly, while removing the tip using a snare, a thrombus was released and tpa was administered.The current status of the patient was unknown.
 
Additional Manufacturer Narrative
H10: manufacturing review: based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.However, the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Investigation summary: the sample was returned for evaluation.The returned sample was found in used condition without stent and the inner catheter cardan tube was found broken twice at the distal end which leads to confirmed result for catheter break.Images demonstrating the detached pieces inside patient were not provided.A 5f introducer with 0.035" guidewire were used for access, the vessel was not tortuous but calcified, the lesion was pre dilated, and the user did no experience difficulty during deployment action.The system was correctly held at the stability sheath, and a sudden force increase was not felt during removal but the guidewire was running roughly inside the system.Therefore, based on the information available the investigation is closed with confirmed result for inner catheter break.A definite root cause for the reported event could not be determined.Labeling review: in reviewing the relevant labeling for this product, the potential issue was found addressed.The instructions for use states: 'do not constrict the delivery system during stent deployment.If excessive force is felt during stent deployment, do not force the stent system.Remove the stent system and replace with a new unit.' regarding pre dilation the instructions for use states: 'pre-dilatation of the lesion with a balloon dilatation catheter is recommended.' under materials required the instructions for use states: '5f (1.67 mm) or larger introducer sheath (¿); 0.014-inch (0.36 mm) - 0.035-inch (0.89 mm) diameter guidewire'.Regarding insertion and removal difficulty of the delivery system the instructions for use states: 'if resistance is met during stent system introduction, the stent system should be withdrawn and another stent system should be used.', and 'if resistance is met while retracting the delivery system over a guidewire, remove the delivery system and guidewire together.' holding and handling of the system throughout deployment was found sufficiently described.H10: d4 (expiry date: 07/2025), g3, h6 (method) h11: h6 (result, conclusion) h11: section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : see h10.
 
Event or Problem Description
It was reported that during a stent placement procedure in the left superficial femoral artery via common femoral access, the guidewire allegedly felt resistance when advanced inside the delivery system and then the stent was delivered and removed successfully.It was further reported that there was an unknown object was found in the artery and when the delivery system was verified it was allegedly found that the tip of the delivery system was missing.Reportedly, while removing the tip using a snare, a thrombus was released and tpa was administered.The current status of the patient was unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFESTENT 5F VASCULAR STENT
Common Device Name
VASCULAR STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM  76227
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM   76227
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key18157517
Report Number9681442-2023-00374
Device Sequence Number18140662
Product Code NIP
UDI-Device Identifier00801741120152
UDI-Public(01)00801741120152
Combination Product (Y/N)N
PMA/510(K) Number
P070014
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number5F060403CS
Device Lot NumberANGU2110
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/13/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/23/2023
Supplement Date Received by Manufacturer11/23/2023
Initial Report FDA Received Date11/17/2023
Supplement Report FDA Received Date11/30/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age78 YR
Patient SexMale
Patient RaceWhite
-
-